Table 5.
Comparison of published reports detailing characteristics of patients with brain metastases from liposarcoma and rhabdomyosarcoma.
| Case author | Age, sex | IB yr. | BM treatment | OS Mo |
|---|---|---|---|---|
| Rhabdomyosarcoma | ||||
| Ahola et al., 1998 [84] | 13 M | 0.7 | SR | 14 |
| Andersen-Ranberg and Helmer-Hansen, 1987 [83] | 19 M | 0.5 | NR | 6+ |
| Flannery et al., 2010 [15] | 18 F | 5.0 | GKSRS, WBRT | 60 |
| Ho, 1979 [68] | 79 M | — | D | — |
| Kebudi et al., 2005 [3] | 11 M | 0 | RT, Chemo | 3 |
| Kleinert et al., 1985 [90] | 14 F | D | 48 | |
| Noda et al., 1995 [91] | 2 M | 0.5 | Chemo, RT | 32+ |
| Ogose et al., 1999 [33] | 7 F, 16 M | NR, 0.2 | Chemo, RT | 4, 4 |
| Osawa et al., 2011 [88] |
N = 3 6–18, M (3) |
1.1–12.2 | SR, RT, Chemo | 21–207 |
| Paulino et al., 2003 [17] |
N = 8 1.7–18, M (6) |
NR | WBRT, Chemo | 2–63 |
| Rodriguez-Galindo et al., 2001 [85] |
N = 5 Newborn, F |
0.1–1.1 | NR | 1.5–24 |
| Salvati et al., 2010 [2] |
N = 2 20–22, M (1) |
0.2–0.3 | SR | 12.8 |
|
| ||||
| Liposarcoma | ||||
| Arepally et al., 1996 [76] | 56 M | 312 | SR, WBRT | 324 |
| Bailey et al., 2001 [74] | 54 F | 108 | SR, WBRT | Alive at 114 |
| Can et al., 1993 [82] | 22 M | 0 | none | |
| Ferguson et al., 2006 [79] | 48 F | 276 | RT | 278 |
| Fitzpatrick et al., 1999 [77] | 74 F | 24 | SR | Alive at 30 |
| Haft et al., 1988 [80] | 52 F | 216 | SR (total), chemo | 228 |
| Kumar and Teasdale, 2000 [81] | 73 F | 12 | SR | Alive at 12 |
| Salvati et al., 2010 [2] | 48 M | NR | SR | NR |
| Utsunomiya et al., 1999 [75] | 44 M | 72 | SR (subtotal) | 77 |
IB: Interval to brain metastasis (mo); OS: overall survival in months; M: male; F: female; chemo: chemotherapy; SR: surgical resection; GKSRS: Gamma knife stereotactic radiosurgery; ICH: intracerebral hemorrhage on presentation; WBRT: whole brain radiotherapy; RT: radiotherapy; D: death prior to treatment; NR: not reported; UK: unknown; asurvival after craniotomy.